Virginia Drug Discovery Consortium

The Virginia Drug Discovery Consortium (VaDDC) has a threefold mission:

To promote the growth and advancement of drug discovery and development programs at universities and research institutes within Virginia, particularly through inter-institutional collaboration.

To help the pharmaceutical industry bring life-saving and quality of life solutions to patients through innovative collaborations with Virginia’s best and brightest researchers.

To promote and enhance the attractiveness of Virginia as an environment for pharmaceutical and biotech companies.



2nd ASPET/ADDC Academic Drug Discovery Colloquium

On October 12-13, 2017, on the NIH central campus in Bethesda there will be a meeting entitled “Fueling Innovation: Public Programs Driving Drug Discovery.” The meeting is hosted by the American Society for Pharmacology and Experimental Therapeutics,and the Academic Drug Discovery Consortium.


VirginiaCancerRx in the News!

John Lazo (VaDDC, Univ. of Virginia Pharmacology), David Kingston (VaDDC, Virginia Tech Chemistry) and Thomas Loughran (Director, Univ. of Virginia Cancer Center) were interviewed by Charlottesville’s CBS affiliate regarding Virginia Drug Discovery Consortium’s 2017...

read more


Want to work with us?

If you are interested in supporting this initiative, please contact us.